Cellular Plasticity Underlying the Pathophysiology of Type 2 Diabetes 2013


Programme and Research Focus

EFSD has established this new European Diabetes Research Programme in Cellular Plasticity Underlaying the Pathophysiology of Type 2 Diabetes to encourage new projects aimed at advancing current knowledge in this domain. To achieve the goals and objectives of this Programme, EFSD invite applications by issuing this "Request for Applications" (RFA), which indicates joint funding as well as areas of research emphasis.

While it is recognised that type 2 diabetes is the consequence of inadequate beta cell function in the face of insulin resistance, the underlying molecular defects remain elusive. Recent results have implicated cellular plasticity in the disease process, with partial or complete dedifferentiation of beta cells and insulin target cells. A more complete understanding of such cellular plasticity in type 2 diabetes and the potential for its reversibility may lead to the development of novel therapies.

While all proposals relevant to this research focus will be considered, those projects studying the effect of GLP-1 or DPP4 inhibition on cellular plasticity underlying the recovery of beta cell function will be particularly welcome.

Termini IISPV

Cal comunicar abans del 17 d’octubre de 2013 que es vol participar a la convocatòria, enviant un e-mail a europa@iispv.cat . Termini: 28 d’octubre de 2013. L’IISPV gestiona les ajudes dels seus investigadors, no és l’entitat convocant.

Termini Oficial

Deadline for submission of applications: 1 November 2013

Estàs interessat?

Omple el següent formulari per rebre més informació: